This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verdier, I.
Right arrow Articles by Vandenesch, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verdier, I.
Right arrow Articles by Vandenesch, F.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, March 2004, p. 1024-1027, Vol. 48, No. 3
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.3.1024-1027.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Staphylococcus aureus Isolates with Reduced Susceptibility to Glycopeptides Belong to Accessory Gene Regulator Group I or II

Isabelle Verdier, Marie-Elisabeth Reverdy, Jerome Etienne, Gérard Lina, Michèle Bes, and François Vandenesch*

National Reference Laboratory for Staphylococci, INSERM E0230, IFR62, Faculté de Médecine Laennec, Lyon, France,

Received 2 June 2003/ Returned for modification 11 August 2003/ Accepted 30 October 2003

We used multiplex PCR to determine the agr group membership of 18 European glycopeptide heterointermediate and intermediate-resistant Staphylococcus aureus strains. Of the 15 agr group I strains, 13 were resistant and 2 were susceptible to methicillin. The remaining three strains, like the United States and Japanese control strains, belonged to agr group II.

* Corresponding author. Mailing address: Faculté de Médecine Laennec, National Reference Centre for Staphylococci, IFR62, INSERM E0230, 7 rue Guillaume Paradin, 69372 Lyon cedex 08, France. Phone: 33 4 78 77 86 57. Fax: 33 4 78 77 86 58. E-mail: denesch{at}univ-lyon1.fr.

Antimicrobial Agents and Chemotherapy, March 2004, p. 1024-1027, Vol. 48, No. 3
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.3.1024-1027.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Luczak-Kadlubowska, A., Krzyszton-Russjan, J., Hryniewicz, W. (2006). Characteristics of Staphylococcus aureus Strains Isolated in Poland in 1996 to 2004 That Were Deficient in Species-Specific Proteins. J. Clin. Microbiol. 44: 4018-4024 [Abstract] [Full Text]  
  • Howden, B. P., Johnson, P. D. R., Ward, P. B., Stinear, T. P., Davies, J. K. (2006). Isolates with Low-Level Vancomycin Resistance Associated with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia.. Antimicrob. Agents Chemother. 50: 3039-3047 [Abstract] [Full Text]  
  • Francois, P., Koessler, T., Huyghe, A., Harbarth, S., Bento, M., Lew, D., Etienne, J., Pittet, D., Schrenzel, J. (2006). Rapid Staphylococcus aureus agr Type Determination by a Novel Multiplex Real-Time Quantitative PCR Assay.. J. Clin. Microbiol. 44: 1892-1895 [Abstract] [Full Text]  
  • Robinson, D. A., Monk, A. B., Cooper, J. E., Feil, E. J., Enright, M. C. (2005). Evolutionary Genetics of the Accessory Gene Regulator (agr) Locus in Staphylococcus aureus. J. Bacteriol. 187: 8312-8321 [Abstract] [Full Text]  
  • Steenbergen, J. N., Alder, J., Thorne, G. M., Tally, F. P. (2005). Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. J Antimicrob Chemother 55: 283-288 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»